Erlotinib and Bevacizumab in Treating Women With Stage IV Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2005 by National Cancer Institute (NCI).
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00054132
First received: February 5, 2003
Last updated: April 21, 2009
Last verified: April 2005